Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 21, 2022
Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome
P Johnson, J K Chan, I M Vavasour, et al.
AJNR. American Journal of Neuroradiology
|
November 14, 2015
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
A Traboulsee, J H Simon, L Stone, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels
I M Vavasour, P Becquart, J Gill, et al.
Journal of Neurology
|
July 6, 2020
Treatment of MOG antibody associated disorders: results of an international survey
D H Whittam, V Karthikeayan, E Gibbons, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 21, 2022
Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome
P Johnson, J K Chan, I M Vavasour, et al.
AJNR. American Journal of Neuroradiology
|
November 14, 2015
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
A Traboulsee, J H Simon, L Stone, et al.
Multiple Sclerosis and Related Disorders
|
December 6, 2021
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels
I M Vavasour, P Becquart, J Gill, et al.
Journal of Neurology
|
July 6, 2020
Treatment of MOG antibody associated disorders: results of an international survey
D H Whittam, V Karthikeayan, E Gibbons, et al.
Page
of 3